Gilead Sciences to pay $97 million to settle US govt kickback probe

Topics Gilead Sciences

By Jonathan Stempel WASHINGTON (Reuters) - Gilead Sciences Inc has agreed to pay $97 million to resolve U.S. government claims it used a purportedly independent charity to pay illegal kickbacks to cover Medicare patients' out-of-pocket costs for its pulmonary arterial hypertension drug Letairis.

The U.S. Department of Justice said on Wednesday the settlement resolves allegations that Gilead improperly used the Caring Voice Coalition as a conduit to cover thousands of patients' co-payment obligations. Gilead's actions.....

This article is no longer available in our repository.

There could be multiple reasons for this.